Interleukin-1 alpha (Dainippon)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-1 alpha (Dainippon)
Drug Alias NamerIL-1 alphaInterleukin-1-alpha - Dainippon Sumitomo Pharma
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionMacrophage colony stimulating factor 2 stimulantsInterleukin-1 alpha stimulantsColony stimulating factor stimulants
TargetsInterleukin-1 alphaColony stimulating factorMacrophage colony stimulating factor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche LtdSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia